RVCL - retinal vasculopathy cerebral leukoencephalopathy

Clinical trials for RVCL - retinal vasculopathy cerebral leukoencephalopathy explained in plain language.

Never miss a new study

Get alerted when new RVCL - retinal vasculopathy cerebral leukoencephalopathy trials appear

Sign up with your email to follow new studies for RVCL - retinal vasculopathy cerebral leukoencephalopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Hope for RVCL: experimental drug tested in tiny trial

Disease control Completed

This phase 2 trial tested the drug crizanlizumab in 18 people with RVCL, a rare and fatal genetic condition that damages small blood vessels in the brain and eyes. There is currently no treatment for RVCL. The study measured changes in brain lesions on MRI scans to see if the dru…

Matched conditions: RVCL - RETINAL VASCULOPATHY CEREBRAL LEUKOENCEPHALOPATHY

Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

RVCL - retinal vasculopathy cerebral leukoencephalopathy

Get alerted when new RVCL - retinal vasculopathy cerebral leukoencephalopathy trials appear

Hope for RVCL: experimental drug tested in tiny trial